KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Treasury Shares (2017 - 2026)

Guardant Health's Treasury Shares history spans 1 years, with the latest figure at $45.0 million for Q3 2025.

  • On a quarterly basis, Treasury Shares rose 389.29% to $6.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.3 million, a 389.29% increase, with the full-year FY2025 number at $6.3 million, up 389.29% from a year prior.
  • Treasury Shares hit $6.3 million in Q4 2025 for Guardant Health, up from $1.3 million in the prior quarter.
  • Over the last five years, Treasury Shares for GH hit a ceiling of $8.4 million in Q1 2025 and a floor of $374596.0 in Q4 2021.
  • Historically, Treasury Shares has averaged $2.6 million across 5 years, with a median of $2.3 million in 2021.
  • Biggest five-year swings in Treasury Shares: skyrocketed 884.5% in 2022 and later plummeted 80.02% in 2023.
  • Tracing GH's Treasury Shares over 5 years: stood at $374596.0 in 2021, then skyrocketed by 884.5% to $3.7 million in 2022, then plummeted by 38.7% to $2.3 million in 2023, then plummeted by 42.91% to $1.3 million in 2024, then skyrocketed by 389.29% to $6.3 million in 2025.
  • Business Quant data shows Treasury Shares for GH at $45.0 million in Q3 2025, $45.0 million in Q2 2025, and $45.0 million in Q1 2025.